Melasma: How hormones can modulate skin pigmentation.
Contraceptives, Oral
/ adverse effects
Estrogens
/ blood
Female
Genetic Predisposition to Disease
Hormone Replacement Therapy
/ adverse effects
Humans
Male
Melanosis
/ blood
Pregnancy
Progesterone
/ blood
Receptors, Estrogen
/ metabolism
Receptors, Progesterone
/ metabolism
Risk Factors
Skin
/ drug effects
Skin Pigmentation
/ drug effects
Sunlight
/ adverse effects
hormones
melasma
pigmentation
Journal
Journal of cosmetic dermatology
ISSN: 1473-2165
Titre abrégé: J Cosmet Dermatol
Pays: England
ID NLM: 101130964
Informations de publication
Date de publication:
Apr 2019
Apr 2019
Historique:
received:
11
10
2018
revised:
28
12
2018
accepted:
07
01
2019
pubmed:
20
2
2019
medline:
15
1
2020
entrez:
20
2
2019
Statut:
ppublish
Résumé
We described-along with a genetic predisposition and exposure to sunlight, as the main factors for melasma development-pregnancy, hormonal therapies, and oral contraceptive pills. Whilst hormonal alteration or therapies are frequently reported in literature in association with melasma, studies analyzing the laboratoristic correlation are limited. We review data published on hormones variations both in women and males with melasma and report some peculiar clinical cases that further demonstrate how the relationship between hormone secretion and melasma development is difficult to be defined.
Substances chimiques
Contraceptives, Oral
0
Estrogens
0
Receptors, Estrogen
0
Receptors, Progesterone
0
Progesterone
4G7DS2Q64Y
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
458-463Informations de copyright
© 2019 Wiley Periodicals, Inc.